Metraipolis › archive › dc_24fa46bb5a1f

The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration — Europe PMC PMID:42395176

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42395176
DOI: 10.3389/fendo.2026.1822475
License (as archived): solo-consultazione
Archived: 2026-10-19T08:14:44.265Z
SHA-256 of the archived text: 6a0d81169dae811083d51bc4ff744d94f5acf288dcd238ea9d16b38b1d12bbc9
Stable URL of this page: https://metraipolis.com/documento/dc_24fa46bb5a1f

How to cite

The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration — Europe PMC PMID:42395176 — Europe PMC (en), https://europepmc.org/article/MED/42395176 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_24fa46bb5a1f (Metraipolis archive dc_24fa46bb5a1f, sha256 6a0d81169dae811083d51bc4ff744d94f5acf288dcd238ea9d16b38b1d12bbc9)

BibTeX

@misc{dc24fa46bb5a1f,
  title = {The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration — Europe PMC PMID:42395176},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42395176},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_24fa46bb5a1f; sha256 6a0d81169dae811083d51bc4ff744d94f5acf288dcd238ea9d16b38b1d12bbc9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42395176. Agents can read the archived copy with the MCP tool read_document.